Your browser doesn't support javascript.
loading
Easy-to-use algorithm would provide faster diagnoses for mucopolysaccharidosis type I and enable patients to receive earlier treatment.
Tylki-Szymanska, Anna; De Meirleir, Linda; Di Rocco, Maja; Fathalla, Waseem M; Guffon, Nathalie; Lampe, Christina; Lund, Allan M; Parini, Rossella; Wijburg, Frits A; Zeman, Jiri; Scarpa, Maurizio.
  • Tylki-Szymanska A; Department of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, Poland.
  • De Meirleir L; Department of Paediatric Neurology and Metabolic Diseases, Brussels, Belgium.
  • Di Rocco M; Unit of Rare Diseases, Department of Paediatrics, IRCCS Giannina Gaslini, Genova, Italy.
  • Fathalla WM; Division of Child Neurology, Department of Pediatrics, Mafraq Hospital, Bani Yas, Abu Dhabi, United Arab Emirates.
  • Guffon N; Reference Centre of Metabolic Diseases, Hôpital Femme Mère Enfant (HFME), Bron, France.
  • Lampe C; Center for Rare Diseases, Clinic for Paediatric and Adolescent Medicine, HELIOS Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
  • Lund AM; Centre for Inherited Metabolic Diseases, Departments of Paediatrics and Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
  • Parini R; Rare Metabolic Diseases Unit, Paediatric Clinic, Fondazione MBBM, San Gerardo University Hospital, Monza, Italy.
  • Wijburg FA; Department of Paediatrics, Academic Medical Center, Amsterdam, The Netherlands.
  • Zeman J; Department of Pediatrics and Adolescent Medicine, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
  • Scarpa M; Center for Rare Diseases, Clinic for Paediatric and Adolescent Medicine, HELIOS Dr. Horst Schmidt Kliniken Wiesbaden, Wiesbaden, Germany.
Acta Paediatr ; 107(8): 1402-1408, 2018 08.
Article en En | MEDLINE | ID: mdl-29797470
ABSTRACT

AIM:

The aim of this study was to develop an algorithm to prompt early clinical suspicion of mucopolysaccharidosis type I (MPS I).

METHODS:

An international working group was established in 2016 that comprised 11 experts in paediatrics, rare diseases and inherited metabolic diseases. They reviewed real-world clinical cases, selected key signs or symptoms based on their prevalence and specificity and reached consensus about the algorithm. The algorithm was retrospectively tested.

RESULTS:

An algorithm was developed. In patients under two years of age, kyphosis or gibbus deformity were the key symptoms that raised clinical suspicion of MPS I and in those over two years they were kyphosis or gibbus deformity, or joint stiffness or contractures without inflammation. The algorithm was tested on 35 cases, comprising 16 Hurler, 10 Hurler-Scheie, and nine Scheie patients. Of these 35 cases, 32 (91%) - 16 Hurler, nine Hurler-Scheie and seven Scheie patients - would have been referred earlier if the algorithm had been used.

CONCLUSION:

The expert panel developed and tested an algorithm that helps raise clinical suspicion of MPS I and would lead to a more prompt final diagnosis and allow earlier treatment.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Algoritmos / Tamizaje Neonatal / Mucopolisacaridosis I / Diagnóstico Precoz Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Child / Child, preschool / Female / Humans / Male / Newborn Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Algoritmos / Tamizaje Neonatal / Mucopolisacaridosis I / Diagnóstico Precoz Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Child / Child, preschool / Female / Humans / Male / Newborn Idioma: En Año: 2018 Tipo del documento: Article